OS Therapies, Inc., a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced that it received a Notice of Allowance from the United ...

Principal Financial Group Inc. decreased its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 6.7% in the fourth quarter, according to the company in its most recent ...

The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...

Empa researchers have developed a new 3D tissue analysis for thyroid tumors. This special X-ray technique uses artificial ...

Creative Biolabs Creative Biolabs offers novel approaches in exosome science through its sophisticated technology, providing unique service ...

Rozlyn Khan has accused Hina Khan of faking her cancer diagnosis. Rozlyn now claims to have accessed Hina's PET scan reports, which reveal that she had stage 2 and not stage 3 cancer.

Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that ...

Aptamers are single-stranded DNA or RNA molecules with unique 3D structures that allow for specific binding to a wide variety of ions and molecules. Due to their unique properties, aptamers have been ...

A Cuban woman named María Julia Gómez Pérez, residing in Santa Clara, has taken to social media to expose the dire ...

The following is a summary of "Prophylactic cranial irradiation improved the prognosis in pT1-2N0M0 small cell lung cancers ...

The firm plans to build on its organ and tissue modeling technology to develop more sophisticated tests, including full-body digital twins.